Skip to main content
رجوع
Watch Compare

Vivani Medical, Inc.

جودة البيانات: 83%
VANI
NASDAQ Manufacturing Measuring & Analyzing Instruments
KWD 1.14
▲ KWD 0.07 (6.54%)
6 months return
—
Momentum
Neutral
ROE
-855.73%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-855.73%
أقل من متوسط القطاع (-54.47%)
ROIC-107.76%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.61
Interest CoverageN/A

التقييم

PE (TTM)
-3.29
أقل من متوسط القطاع (-1.49)
P/B Ratio66.93
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -25.49 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

3 محللين
Buy
+324.0%
upside to target
الحالي
KWD 1.14
Consensus Target
KWD 4.83
KWD 3.50
أدنى
KWD 7.00
أعلى
التوقعات
ربحية السهم المستقبلية
-KWD 0.38
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.08 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.11 -KWD 0.12 -KWD 0.11 -KWD 0.09 — —
Estimate -KWD 0.11 -KWD 0.10 -KWD 0.11 -KWD 0.09 -KWD 0.08 -KWD 0.08
المفاجأة -4.76% -20.00% 0.00% 0.00% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -855.73% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -26.61 M
ROE -855.73% ROA -98.64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -25.49 M
ROIC -107.76% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.61
Debt / Equity N/A Current Ratio 0.61
Interest Coverage N/A Asset Turnover N/A
Working Capital -2.66 M Tangible Book Value 1.31 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -3.29 · EV/EBITDA: N/A
P/E Ratio -3.29 Forward P/E N/A
P/B Ratio 66.93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29.10%
Market Cap 87.61 M Enterprise Value 84.98 M

Per Share

EPS: -0.43 · FCF/Share: -0.30
EPS (Diluted TTM) -0.43 Revenue / Share N/A
FCF / Share -0.30 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 95.81% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 95.81%
SBC-Adj. FCF -26.98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -26.61 M -23.49 M -25.65 M -13.89 M -8.92 M
EPS (Diluted) -0.43 -0.43 — — —
Gross Profit — — — — 130,000.0
Operating Income -27.56 M -24.68 M -26.97 M -21.24 M -8.93 M
EBITDA — — — — —
R&D Expenses 18.13 M 15.75 M 16.97 M 14.17 M 2.37 M
SG&A Expenses — — — — —
D&A 424,000.0 400,000.0 357,000.0 381,000.0 70,000.0
Interest Expense — — — — —
Income Tax 2,000.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 39.39 M 41.56 M 45.80 M 51.13 M 70.88 M
Total Liabilities 23.66 M 23.95 M 25.04 M 6.82 M 2.51 M
Shareholders' Equity 15.73 M 17.61 M 20.76 M 44.31 M 68.37 M
Total Debt — — — — —
Cash & Equivalents 16.23 M 18.35 M 20.65 M — 69.59 M
Current Assets 17.90 M 20.44 M 23.06 M 47.53 M 70.51 M
Current Liabilities 6.60 M 5.99 M 5.72 M 6.82 M 2.46 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -3.3 -1.5
P/B 66.9 1.6
ROE % -855.7 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3